within Pharmacolibrary.Drugs.ATC.C;

model C01CA08
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.4,
    Cl             = 0.0003333333333333333,
    adminDuration  = 600,
    adminMass      = 50 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0025,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0005,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>C01CA08</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Oxedrine (also known as synephrine) is a sympathomimetic drug, primarily acting as an alpha-adrenergic agonist. It has been used as a vasopressor in hypotensive states, nasal decongestant, and as a mydriatic agent. Its clinical use today is limited or obsolete, and the drug is not widely approved in modern therapeutic guidelines.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for healthy adult individuals. No published, peer-reviewed PK parameters for pharmaceutical oxedrine (synephrine) as C01CA08 currently exist.</p><h4>References</h4><ol><li><p>Stohs, SJ, et al., &amp; Ray, SD (2020). p-Synephrine, ephedrine, p-octopamine and m-synephrine: Comparative mechanistic, physiological and pharmacological properties. <i>Phytotherapy research : PTR</i> 34(8) 1838–1846. DOI:<a href=\"https://doi.org/10.1002/ptr.6649\">10.1002/ptr.6649</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/32101364/\">https://pubmed.ncbi.nlm.nih.gov/32101364</a></p></li><li><p>Si-Qi, L, et al., &amp; Guo-Shun, S (2025). Pharmacokinetics comparison of seven active components after oral administration of Zhizhu pill using raw and processed Rhizoma Atractylodis Macrocephalae. <i>Journal of chromatography. B, Analytical technologies in the biomedical and life sciences</i> 1256 124521–None. DOI:<a href=\"https://doi.org/10.1016/j.jchromb.2025.124521\">10.1016/j.jchromb.2025.124521</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/40015007/\">https://pubmed.ncbi.nlm.nih.gov/40015007</a></p></li><li><p>da Silva-Pereira, JF, et al., &amp; Bracht, A (2016). Fast hepatic biotransformation of p-synephrine and p-octopamine and implications for their oral intake. <i>Food &amp; function</i> 7(3) 1483–1491. DOI:<a href=\"https://doi.org/10.1039/c6fo00014b\">10.1039/c6fo00014b</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/26883936/\">https://pubmed.ncbi.nlm.nih.gov/26883936</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end C01CA08;
